tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NERV is currently covered by 3 analysts with an average price target of $9.6. This is a potential upside of $6.71 (232.18%) from yesterday's end of day stock price of $2.89.
Minerva Neurosciences's activity chart (see below) currently has 43 price targets and 45 ratings on display. The stock rating distribution of NERV is 75% HOLD and 25% BUY.
Analysts average stock forecasts to be materialized ratio is 46.96% with an average time for these price targets to be met of 249.33 days.
Highest price target for NERV is $14, Lowest price target is $7, average price target is $9.6.
Most recent stock forecast was given by ANDREW TSAI from JEFFERIES on 14-Aug-2026. First documented stock forecast 28-Jul-2014.
Currently out of the existing stock ratings of NERV, 3 are a HOLD (75%), 1 are a BUY (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Aug-2026
$10
$6.6 (194.12%)
$3
2 months ago
(14-Aug-2026)
1/2 (50%)
$5.42 (118.34%)
324
Hold Since 14-Aug-2026
$10
$6.82 (214.47%)
$16
2 months ago
(14-Aug-2026)
1/3 (33.33%)
$5.42 (118.34%)
413
Buy Since 18-Oct-2016
$14
$10.82 (340.25%)
$21
5 months 29 days ago
(15-Apr-2026)
0/12 (0%)
$7.82 (126.54%)
Hold Since 09-Mar-2023
$7
$2.63 (60.18%)
$4
7 months 2 days ago
(12-Mar-2026)
11/12 (91.67%)
$-0.69 (-8.97%)
241
Buy Since 14-May-2020
$7
$3.82 (120.13%)
$48
3 years 7 months 5 days ago
(09-Mar-2023)
1/3 (33.33%)
$5.19 (286.74%)
62
What is NERV (Minerva Neurosciences) average time for price targets to be met?
Which analyst most recently updated their price target on NERV (Minerva Neurosciences)?
Which analyst has the current lower performing score on NERV (Minerva Neurosciences) with a proven track record?
Which analyst has the most public recommendations on NERV (Minerva Neurosciences)?
Which analyst is the currently most bullish on NERV (Minerva Neurosciences)?
Which analyst is the currently most reserved on NERV (Minerva Neurosciences)?
